4-Aminobenzyl Alcohol for Anti-Infective Small Molecule Drug Candidate R&D
Product: 4-Aminobenzyl Alcohol (P-Aminobenzyl Alcohol)
Client Background: An emerging domestic pharmaceutical company focused on developing antimicrobial peptidomimetics.
Project Requirements:

• Serve as a linker unit with high functional group compatibility.
• Meet >99% HPLC purity, low colority, and odor-free specifications.

Wealsun’s Solution:

• Optimized synthetic route via reductive amination to enhance impurity control.
• Supplied samples in 10g, 100g, and 500g batches, with all quality control parameters consistently met.

Outcomes:

• The client successfully completed in vivo efficacy evaluations and included Wealsun in their approved synthetic service supplier system.
• Supported the establishment of a next-generation anti-infective lead compound screening platform.